Table 2.
Indicators of Severity of Illness Associated with Extreme Weight Lossa
| Variable | Number (%) of women with extreme weight loss (n = 214) | Number (%) of women without extreme weight loss (n = 605) | Odds ratio (95% CI) | p value |
|---|---|---|---|---|
| Hospitalization | 170 (79.4%) | 317 (52.4%) | 3.5 (2.4-5.1) | <0.001 |
| Ondansetron (Zofran) use | 137 (64.0%) | 325 (53.7%) | 1.5 (1.1-2.1) | 0.010 |
| Intravenous fluid use | 182 (85.1%) | 412 (68.1%) | 2.7 (1.8-4.0) | <0.001 |
| Parenteral nutrition use | 72 (33.6%) | 96 (15.9%) | 2.7 (1.9-3.9) | <0.001 |
| Change of physician | 83 (38.8%) | 134 (22.1%) | 2.2 (1.6-3.1) | <0.001 |
a
Extreme weight loss was defined as a loss of ≥15% of the prepregnancy weight in the pregnancy with the most severe weight loss of all reported pregnancies.